<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet"/>
    <link href="./static/css/outliers.css" rel="stylesheet"/>
    <meta charset="UTF-8"/>
</head>

<body>
    <div class="container"><h1>Static outliers for Workington PCN</h1>
<p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
    explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
    prescribers and organisations to audit and review prescribing.</p>
<p>The below reports have been developed to use &#8220;z-scores&#8221; to automatically identify prescribing patterns at a chemical level which are furthest away from &#8220;typical prescribing&#8221; and can be classified as an &#8220;outlier&#8221;. It is important to remember that
    this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
    method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
    We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the &#8220;z-score&#8221;, which is a measure
    of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your &#8220;z-scores&#8221; to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
    for prescribing lower than its peers.</p>
<p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&amp;entry.2016356131=pcn+U67303">survey</a>
    or emailing us at
    <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
    feedback.
</p><h2>Prescribing where Workington PCN is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=0307000Q0&amp;denomIds=3.7&amp;selectedTab=summary">Erdosteine</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>61</td>
      <td>Mucolytics</td>
      <td>1078</td>
      <td>0.06</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>8.77</td>
      <td><img class="zoom" src="data:image/png;base64,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"/></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=0307000Q0AAAAAA&amp;denomIds=3.7&amp;selectedTab=summary" target="_blank">Erdosteine 300mg capsules : 59</a><br/><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=0307000Q0BBAAAA&amp;denomIds=3.7&amp;selectedTab=summary" target="_blank">Erdotin 300mg capsules : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=0202040D0&amp;denomIds=2.2.4&amp;selectedTab=summary">Amiloride hydrochloride with loop diuretics</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>11</td>
      <td>Potassium sparing diuretics and compounds</td>
      <td>33</td>
      <td>0.33</td>
      <td>0.01</td>
      <td>0.04</td>
      <td>8.26</td>
      <td><img class="zoom" src="data:image/png;base64,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"/></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=0202040D0AAAAAA&amp;denomIds=2.2.4&amp;selectedTab=summary" target="_blank">Amiloride 5mg / Bumetanide 1mg tablets : 11</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=1201010G0&amp;denomIds=12.1.1&amp;selectedTab=summary">Hydrocortisone acetate</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>89</td>
      <td>Otitis externa</td>
      <td>440</td>
      <td>0.20</td>
      <td>0.03</td>
      <td>0.03</td>
      <td>6.56</td>
      <td><img class="zoom" src="data:image/png;base64,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"/></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=1201010G0AAACAC&amp;denomIds=12.1.1&amp;selectedTab=summary" target="_blank">Gentamicin 0.3% / Hydrocortisone acetate 1% ear drops : 89</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=0501070F0&amp;denomIds=5.1.7&amp;selectedTab=summary">Chloramphenicol</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Some other antibacterials</td>
      <td>93</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>5.96</td>
      <td><img class="zoom" src="data:image/png;base64,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"/></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=0501070F0AAAAAA&amp;denomIds=5.1.7&amp;selectedTab=summary" target="_blank">Chloramphenicol 250mg capsules : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=1104020B0&amp;denomIds=11.4.2&amp;selectedTab=summary">Antazoline</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>20</td>
      <td>Other anti-inflammatory preparations</td>
      <td>254</td>
      <td>0.08</td>
      <td>0.01</td>
      <td>0.01</td>
      <td>5.59</td>
      <td><img class="zoom" src="data:image/png;base64,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"/></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=1104020B0AAACAC&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Antazoline 0.5% / Xylometazoline 0.05% eye drops : 1</a><br/><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=1104020B0BCAAAC&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Otrivine Antistin 0.5%/0.05% eye drops : 19</a></div></td></tr></tbody></table>

        <h2>Prescribing where Workington PCN is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=0605010S0&amp;denomIds=6.5.1&amp;selectedTab=summary">Somatropin</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Hypothalamic &amp; anterior pituitary hormone &amp; antioestrogens</td>
      <td>3</td>
      <td>0.00</td>
      <td>0.89</td>
      <td>0.25</td>
      <td>-3.49</td>
      <td><img class="zoom" src="data:image/png;base64,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"/></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div/></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=0202040B0&amp;denomIds=2.2.4&amp;selectedTab=summary">Co-amilofruse (Amiloride hydrochloride/frusemide)</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>6</td>
      <td>Potassium sparing diuretics and compounds</td>
      <td>33</td>
      <td>0.18</td>
      <td>0.70</td>
      <td>0.19</td>
      <td>-2.74</td>
      <td><img class="zoom" src="data:image/png;base64,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"/></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=0202040B0AAAAAA&amp;denomIds=2.2.4&amp;selectedTab=summary" target="_blank">Co-amilofruse 5mg/40mg tablets : 6</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=1305030C0&amp;denomIds=13.5.3&amp;selectedTab=summary">Tacrolimus</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>12</td>
      <td>Drugs affecting the immune response</td>
      <td>23</td>
      <td>0.52</td>
      <td>0.80</td>
      <td>0.11</td>
      <td>-2.49</td>
      <td><img class="zoom" src="data:image/png;base64,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"/></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=1305030C0AAAAAA&amp;denomIds=13.5.3&amp;selectedTab=summary" target="_blank">Tacrolimus 0.1% ointment : 10</a><br/><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=1305030C0BBAAAA&amp;denomIds=13.5.3&amp;selectedTab=summary" target="_blank">Protopic 0.1% ointment : 1</a><br/><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=1305030C0BBABAC&amp;denomIds=13.5.3&amp;selectedTab=summary" target="_blank">Protopic 0.03% ointment : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=0501080W0&amp;denomIds=5.1.8&amp;selectedTab=summary">Trimethoprim</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>354</td>
      <td>Sulfonamides and trimethoprim</td>
      <td>502</td>
      <td>0.71</td>
      <td>0.87</td>
      <td>0.07</td>
      <td>-2.45</td>
      <td><img class="zoom" src="data:image/png;base64,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"/></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=0501080W0AAADAD&amp;denomIds=5.1.8&amp;selectedTab=summary" target="_blank">Trimethoprim 100mg tablets : 66</a><br/><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=0501080W0AAAEAE&amp;denomIds=5.1.8&amp;selectedTab=summary" target="_blank">Trimethoprim 200mg tablets : 195</a><br/><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=0501080W0AAAIAI&amp;denomIds=5.1.8&amp;selectedTab=summary" target="_blank">Trimethoprim 50mg/5ml oral suspension sugar free : 96</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=1105000B0&amp;denomIds=11.5&amp;selectedTab=summary">Atropine sulfate</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>7</td>
      <td>Mydriatics and cycloplegics</td>
      <td>28</td>
      <td>0.25</td>
      <td>0.75</td>
      <td>0.22</td>
      <td>-2.26</td>
      <td><img class="zoom" src="data:image/png;base64,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"/></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U67303&amp;numIds=1105000B0AAAEAE&amp;denomIds=11.5&amp;selectedTab=summary" target="_blank">Atropine 1% eye drops : 7</a></div></td></tr></tbody></table>

    </div><script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>